Skip to main content
Caplight Logo









Ozelle Diagnostics

Ozelle Diagnostics

Private
FrankfurtHealthcare & Life Scienceshttps://ozellemed.com/en

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Ozelle Diagnostics operates in Healthcare & Life Sciences and is based in Frankfurt. It was founded in 2014.

Ozelle Diagnostics is a medical technology company that develops AI-powered hematology and multi-functional diagnostic systems for human and veterinary applications.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Biotech Equipment, Healthcare Analytics

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Ozelle Diagnostics Comparables

Compare Ozelle Diagnostics with similar companies based on industry and business-model similarity.

Ozelle Diagnostics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Scopio Labs
84%
Sight Diagnostics
83%
Noul Co. Ltd.
79%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Ozelle Diagnostics Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for Ozelle Diagnostics. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 25, 2026

    Grew 42% QoQ, from 48 to 68 employees.

  • Jul 18, 2026

    Grew 36% QoQ, from 44 to 60 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • attends_eventOct 28, 2026

    Ozelle GmbH attends MEDICA 2026 in Germany and spotlights O-Cyte 1, an automated hematology analyzer that combines AI-assisted classification, complete blood morphology, and scalable throughput.

  • launchesOct 28, 2026

    Ozelle GmbH presents O-Cyte 1 alongside an expanding clinical hematology portfolio featuring integrated multi-test diagnostic systems and compact 7-Diff analyzers at ADLM 2026.

Book a demo to see all news

For institutional investors. Book with your work email.

Ozelle Diagnostics Filings

Explore SEC and related filing metadata, where available.

Ozelle Diagnostics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Ozelle Diagnostics's valuation, stock price, and market status.

Is Ozelle Diagnostics a public or private company?

Ozelle Diagnostics is a private company.

What is the current stock price of Ozelle Diagnostics?

Ozelle Diagnostics is a private company, so its shares have no public market price. Caplight tracks Ozelle Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Ozelle Diagnostics worth (valuation)?

Valuation information for Ozelle Diagnostics is not publicly available.

Can I buy Ozelle Diagnostics stock?

Ozelle Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Ozelle Diagnostics's last funding round?

Funding round information for Ozelle Diagnostics is not publicly available.

Who are the main investors in Ozelle Diagnostics?

Investor information for Ozelle Diagnostics is not publicly disclosed.

Will Ozelle Diagnostics IPO soon?

No public IPO plans have been announced for Ozelle Diagnostics.

How can I track Ozelle Diagnostics secondary market activity?

Caplight tracks bids, offers, and trades in Ozelle Diagnostics's shares on secondary markets.

Firmographic Details

HeadquartersFrankfurt
Employee Range71
Year Founded2014
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?